Skip to content
healthcare.dev
Get a free key

XOLAIR

NDC 50242-040, omalizumab, injection, solution, from Genentech, Inc..

Product NDC
50242-040
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA103976
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-040 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OMALIZUMAB150 mg/1.2mL

Pharmacologic classes

Anti-IgE [EPC]; Decreased IgE Activity [PE]; IgE-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
50242-040-62502420040621 VIAL, SINGLE-USE in 1 CARTON (50242-040-62) / 1.2 mL in 1 VIAL, SINGLE-USE
50242-040-86502420040861 VIAL, SINGLE-USE in 1 CARTON (50242-040-86) / 1.2 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7f6a2191-adfb-48b9-9bfa-0d9920479f0d

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-040

Use it

Look up 50242-040 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-040 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-040. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.